Skip to content

Effect of inhaled peppermint essential oil aromatherapy on postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy

Effect of inhaled peppermint essential oil aromatherapy on postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121875
Enrollment
Unknown
Registered
2026-04-07
Start date
2026-04-10
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholecystitis or gallstones

Interventions

PEO group:Peppermint essential oil aromatherapy

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1.Age 18-64 years old; 2.ASA classification I-III; 3.Patients undergoing laparoscopic cholecystectomy; 4.The operation time is less than three hours; 5.BMI 18.5-30kg/m^2;

Exclusion criteria

Exclusion criteria: 1.refused to sign the informed consent form; 2.participated in other clinical trials within 4 weeks prior to enrollment; 3.patients with pre-operative diagnosed mental illness (including diagnosed bi-directional affective disorder, schizophrenia, etc.); 4.Presence of serious underlying diseases (e.g., cardiovascular and cerebrovascular diseases, respiratory diseases, or abnormalities in liver and kidney functions); 5.People with asthma or allergy to peppermint essential oil; 6.History of chronic pain or recent use of sedative and analgesic drugs; 7.People with olfactory dysfunction;

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative nausea and vomiting;

Secondary

MeasureTime frame
The degree of postoperative nausea and vomiting;Self-Rating Anxiety Scale;The usage rate of rescue antiemetic drugs within 24 hours after surgery;Visual analogue scale(VAS);The initial administration time of the remedial medication;

Countries

China

Contacts

Public ContactZhang Maoyin

The Affiliated Hospital of Xuzhou Medical University

540072028@qq.com+86 516 85805911

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026